KS

Kripal Singh Baxi

Director Director DIN 00434821
DIN 00434821 First appointment Aug 1979 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Aug 1979
Shareholding value Locked Premium profile

About Kripal Singh Baxi

Data last updated:

Kripal Singh Baxi has 47 years in corporate governance. Formerly with 1 company, such as Beckcem Drug International Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 00434821
Primary Designation Director
First Appointment 11 Aug 1979
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Director11 Aug 19791979Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Beckcem Drug International Private Limited
Premium access

Shareholding and investment profile for Kripal Singh Baxi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kripal Singh Baxi

Kripal Singh Baxi has 47 years in corporate governance. Formerly with 1 company, such as Beckcem Drug International Private Limited. Engaged in General Business. Contributes to corporate operations.

Kripal Singh Baxi is associated with 0 companies as a director.

Kripal Singh Baxi has expertise in General Business.

Kripal Singh Baxi has 47 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available